ASCO 2019: Successes and setbacks mark the cancer meeting
Interviewee/Contributor
Bruno Pagliara
Organisation
On-kòs Pharma Consulting
Drug discovery
Combining biologics and small molecules for cancer
Interviewee/Contributor
Amrik Basran
Organisation
Avacta Life Sciences
Microsoft pioneers biological computing
Interviewee/Contributor
Victoria English
Organisation
MedNous
NCI and industry: Moving innovations from the lab to patients
Interviewee/Contributor
Michael Salgaller and Michele Newton
Organisation
US National Cancer Institute
Will gene editing unmask synthetic lethal targets?
Interviewee/Contributor
Ceri Wiggins and Jon Moore
Organisation
Horizon Discovery Group Plc
The need for innovation in neuroscience
Interviewee/Contributor
Jean-Claude Muller
Organisation
MedNous
Meeting Report: Funding rises for early assets
Interviewee/Contributor
Søren Møller
Organisation
Novo Seeds
The productivity of oncology development continues
Interviewee/Contributor
Bruno Pagliara
Organisation
On-kòs Pharma Consulting
Exscientia raises $26 million, partners with Roche
Interviewee/Contributor
Andrew Hopkins
Organisation
Exscientia Ltd
IMI: Building a science infrastructure for Europe
Interviewee/Contributor
Pierre Meulien
Organisation
Innovative Medicines Initiative